These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 16173501)

  • 21. Transcutaneous immunization with novel lipid-based adjuvants induces protection against gastric Helicobacter pylori infection.
    Hickey DK; Aldwell FE; Tan ZY; Bao S; Beagley KW
    Vaccine; 2009 Nov; 27(50):6983-90. PubMed ID: 19800441
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prophylactic and therapeutic efficacy of the epitope vaccine CTB-UA against Helicobacter pylori infection in a BALB/c mice model.
    Guo L; Liu K; Xu G; Li X; Tu J; Tang F; Xing Y; Xi T
    Appl Microbiol Biotechnol; 2012 Sep; 95(6):1437-44. PubMed ID: 22569640
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Progress in vaccine development against Helicobacter pylori.
    Svennerholm AM; Lundgren A
    FEMS Immunol Med Microbiol; 2007 Jul; 50(2):146-56. PubMed ID: 17442014
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of a vaccine against Helicobacter pylori infection.
    Michetti P
    Ital J Gastroenterol Hepatol; 1998 Oct; 30 Suppl 3():S339-41. PubMed ID: 10077770
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A vaccine against Helicobacter pylori infection].
    Presecki V; Katicić M; Kalenić S; Strnad M; Plecko V; Babus V; Dominis M
    Lijec Vjesn; 2002 Sep; 124 Suppl 1():79-82. PubMed ID: 12592824
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Cellular immunity induced by H.pylori vaccine with chitosan as adjuvant].
    Gong YF; Xie Y; Zhou NJ; Chen J; Zhou XJ; Lu NH; Wang CW
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Jul; 23(7):595-9. PubMed ID: 17618575
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transcription profiling analysis of the mechanisms of vaccine-induced protection against H. pylori.
    Walduck A; Schmitt A; Lucas B; Aebischer T; Meyer TF
    FASEB J; 2004 Dec; 18(15):1955-7. PubMed ID: 15456742
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of ISCOMATRIX and ISCOM vaccines for immunisation against Helicobacter pylori.
    Skene CD; Doidge C; Sutton P
    Vaccine; 2008 Jul; 26(31):3880-4. PubMed ID: 18547687
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clearance of Helicobacter pylori infection through immunization: the site of T cell activation contributes to vaccine efficacy.
    Blanchard TG; Eisenberg JC; Matsumoto Y
    Vaccine; 2004 Feb; 22(7):888-97. PubMed ID: 15040942
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral immunogenicity and protective efficacy in mice of a carrot-derived vaccine candidate expressing UreB subunit against Helicobacter pylori.
    Zhang H; Liu M; Li Y; Zhao Y; He H; Yang G; Zheng C
    Protein Expr Purif; 2010 Feb; 69(2):127-31. PubMed ID: 19651219
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathogenesis of Helicobacter pylori and perspectives of vaccine development against an emerging pathogen.
    Rappuoli R; Covacci A; Ghiara P; Telford J
    Behring Inst Mitt; 1994 Dec; (95):42-8. PubMed ID: 7755508
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A truncated form of HpaA is a promising antigen for use in a vaccine against Helicobacter pylori.
    Flach CF; Svensson N; Blomquist M; Ekman A; Raghavan S; Holmgren J
    Vaccine; 2011 Feb; 29(6):1235-41. PubMed ID: 21147129
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic efficacy of oral immunization with attenuated Salmonella typhimurium expressing Helicobacter pylori CagA, VacA and UreB fusion proteins in mice model.
    Liu KY; Shi Y; Luo P; Yu S; Chen L; Zhao Z; Mao XH; Guo G; Wu C; Zou QM
    Vaccine; 2011 Sep; 29(38):6679-85. PubMed ID: 21745524
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [-Development of a mouse model for Helicobacter pylori infection in the human--progress toward vaccination against ulcer disease?-].
    Gallwitz B; Schmidt WE
    Z Gastroenterol; 1996 Mar; 34(3):202-4. PubMed ID: 8650975
    [No Abstract]   [Full Text] [Related]  

  • 35. The nontoxic CTA1-DD adjuvant enhances protective immunity against Helicobacter pylori infection following mucosal immunization.
    Akhiani AA; Stensson A; Schön K; Lycke N
    Scand J Immunol; 2006 Feb; 63(2):97-105. PubMed ID: 16476008
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral immunization of mice with lactic acid bacteria producing Helicobacter pylori urease B subunit partially protects against challenge with Helicobacter felis.
    Corthésy B; Boris S; Isler P; Grangette C; Mercenier A
    J Infect Dis; 2005 Oct; 192(8):1441-9. PubMed ID: 16170763
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PAR2 promotes vaccine-induced protection against Helicobacter infection in mice.
    Velin D; Narayan S; Bernasconi E; Busso N; Ramelli G; Maillard MH; Bachmann D; Pythoud C; Bouzourene H; Michetti P; So A
    Gastroenterology; 2011 Oct; 141(4):1273-82, 1282.e1. PubMed ID: 21703999
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic vaccination against Helicobacter pylori in the beagle dog experimental model: safety, immunogenicity, and efficacy.
    Rossi G; Ruggiero P; Peppoloni S; Pancotto L; Fortuna D; Lauretti L; Volpini G; Mancianti S; Corazza M; Taccini E; Di Pisa F; Rappuoli R; Del Giudice G
    Infect Immun; 2004 Jun; 72(6):3252-9. PubMed ID: 15155627
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunology and vaccines and nanovaccines for Helicobacter pylori infection.
    Milani M; Sharifi Y; Rahmati-Yamchi M; Somi MH; Akbarzadeh A
    Expert Rev Vaccines; 2015 Jun; 14(6):833-40. PubMed ID: 25645086
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vaccine development against Helicobacter pylori infections.
    Haas R; Meyer TF
    Biologicals; 1997 Jun; 25(2):175-7. PubMed ID: 9236048
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.